Drawing for FLAQUEL

USPTO serial 85593591

FLAQUEL

Reviewed by CopyMark Law Group

Reg. 4906876Status 710
Filing date
Status date
Registration date
Mar 1, 2016
Examiner
KEATING, MICHAEL P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FLAQUEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GlaxoSmithKline410 Blackwell StreetLegal Brand ProtectionDurham, NC 27701

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; none for use in oncologySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 9, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 9, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 9, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 9, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 16, 2022C8..CANCELLED SEC. 8 (6-YR)—
Mar 1, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 1, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 15, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 15, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 25, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 10, 2015FIXDELECTRONIC RECORD REVIEW COMPLETE—
Nov 6, 2015ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Nov 3, 2015CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Oct 28, 2015ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Oct 27, 2015PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Oct 21, 2015PETLCOMMUNICATION RECEIVED FROM PETITIONER—
Oct 21, 2015FAXXFAX RECEIVED—
Oct 7, 2015CORVREVIEW OF CORRESPONDENCE COMPLETE—
Sep 30, 2015FAXXFAX RECEIVED—
Sep 30, 2015PILMPETITION INQUIRY LETTER ISSUED—
Sep 21, 2015APETASSIGNED TO PETITION STAFF—
Sep 15, 2015IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 15, 2015PDCBPETITION TO DIRECTOR - CHANGE BASIS - RECEIVED—
Sep 15, 2015D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 5, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 4, 2015EX5GSOU EXTENSION 5 GRANTED—
Feb 13, 2015EXT5SOU EXTENSION 5 FILED—
Feb 13, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 24, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2014EX4GSOU EXTENSION 4 GRANTED—
Oct 16, 2014EXT4SOU EXTENSION 4 FILED—
Oct 16, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 20, 2014EX3GSOU EXTENSION 3 GRANTED—
Mar 4, 2014EXT3SOU EXTENSION 3 FILED—
Mar 4, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2013EX2GSOU EXTENSION 2 GRANTED—
Dec 2, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 16, 2013EXT2SOU EXTENSION 2 FILED—
Oct 16, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 5, 2013EX1GSOU EXTENSION 1 GRANTED—
Apr 5, 2013EXT1SOU EXTENSION 1 FILED—
Apr 5, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 16, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 21, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 21, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2012DOCKASSIGNED TO EXAMINER—
Apr 17, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance